Scholar Rock Holding Corporation, a clinical-phase biopharmaceutical company, is focused on the discovery and development of drugs for the treatment of serious diseases in which protein growth factor signaling plays a critical role. The company is headquartered in Cambridge, Massachusetts. Show more

301 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142, Cambridge, MA, 02142, USA

https://www.scholarrock.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

5.879B

52 Wk Range

$27.07 - $58.49

Previous Close

$49.06

Open

$49.18

Volume

2,100,225

Day Range

$48.29 - $50.11

Enterprise Value

5.605B

Cash

430.5M

Avg Qtr Burn

-82.1M

Insider Ownership

0.78%

Institutional Own.

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Apitegromab (SRK-015) Details Spinal muscular atrophy	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Apitegromab Details Obesity	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Apitegromab (SRK-015) (Myostatin Inhibitor) Details Facioscapulohumeral Muscular Dystrophy	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Apitegromab (SRK-015) (Anti-Myostatin Antibody) Details Facioscapulohumeral Muscular Dystrophy	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SRK-439 Details Obesity	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SRK-181 (TGFβ1) Details Solid tumor/s, Cancer	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.